Earnings$BMY6:59 AM ET6 wires · v6

Bristol Myers Squibb lifts Fiscal Year Outlook as 3Q Revenue Rises

By BORSA NewsroomPublished Oct 29, 2026, 6:59 AM EDTUpdated Oct 29, 2026, 7:06 AM EDT

Bristol Myers Squibb raised its full-year revenue outlook after Q3 revenue rose 7% to $13.1B, beating estimates. Adjusted EPS of $1.35 also topped consensus. The company now expects FY revenue of $49.75B-$50.25B but cut adjusted EPS guidance to $6.35-$6.55 due to charges and licensing costs.

Sentimentbullish 70

Bullish · 70 of 100

Impact60

medium · sector-wide

Confidence95%

high confidence · 6 wires

Eventconfirmed

v6 · alerted to followers

WHAT WE KNOW

Q3 revenue $13.1B, +7% YoY, beat estimate of $12.73B